CRO/Sponsor

The handling of payments is frequently an aspect of contract research organizations work that goes underappreciated and undervalued, despite its critical importance.

Webinar Date/Time: Thursday, November 30th, 2023 at 3pm EST | 12pm PST | 8pm GMT | 9pm CET

Webinar Date/Time: Thursday, November 9th, 2023 Option 1: 9am EST | 6am PST | 2pm GMT | 3pm CET

Webinar Date/Time: Tue, Nov 14, 2023 11:00 AM EST

Pilot study seeks to validate new and more granular outsourcing model classifications in differentiating performance across custom contract-service approaches.

Webinar Date/Time: Tue, Tue, Nov 28, 2023 11:00 AM EST

Webinar Date/Time: Tue, Oct 17, 2023 11:00 AM EDT

Webinar Date/Time: Wed, Sep 20, 2023 10:00 AM EDT

Webinar Date/Time: Tue, Sep 19, 2023 11:00 AM EDT

Webinar Date/Time: Tuesday, September 26th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.

The adaptability and innovative capacity of CROs highlighted in EUCROF survey.

Use the five stages of change model to solve this common paradigm in clinical trials.

Tufts CSDD study breaks down state of the talent pipeline from lens of senior leaders.

Webinar Date/Time: Wednesday, March 29th, 2023 at 11am | 8am PDT | 4pm BST | 5pm CEST

Sunny Kumar, MD, partner at GSR Ventures speaks about venture capital in clinical research at the SCOPE 2023 conference in Orlando, FL.

Murray L. Aitken, SVP of IQVIA speaks about the concerns of smaller biopharma companies getting into clinical trials at the SCOPE 2023 conference in Orlando, FL.

Researchers face various challenges that cause their clinical trials to fail to meet enrollment timelines, among other issues.

Webinar Date/Time: Mon, Feb 13, 2023 10:00 AM EST

Webinar Date/Time: Wednesday, December 7th, 2022 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Differentiating FSO and FSP approaches can better align definitions of models for CROs and sponsors.

Danielle Mitchell, Founder of Black Women in Clinical Research, discusses how her foundation bridges the gap between minority professionals and clinical trials.

Aggressive focus by DOJ has put increased burden on stakeholders to understand their obligations and exposure.

Work across varying therapeutic areas and new technology among reasons why CROs are qualified to advance model.